Skip to main content

Table 2 General demographic and clinical characteristics of patients

From: Level of COVID-19 fear in cancer patients

  Sample size FCV-19S score p value
Age groups
 Under 50 years old 139 22.27 ± 8.09 0.316
 50–65 years old 216 22.35 ± 8.34
 Above 65 years old 131 23.78 ± 9.47
Gender
 Male 162 21.71 ± 9.22 0.085
 Female 324 23.21 ± 23.21
Tumor type
 Breast 215 23.45 ± 8.23 0.435
 Lung 33 21.48 ± 9.92
 Gastrointestinal system 113 22.37 ± 8.76
 Urogenital system 73 22.73 ± 8.35
 Head–neck 19 19.74 ± 8.83
 Other 33 21.97 ± 9.36
Disease stage
 Early 273 23.61 ± 8.3 0.278
 Local advanced 49 22.63 ± 7.75
 Metastatic 164 21.24 ± 9.14
Control patient
 No 368 22.55 ± 8.66 0.448
 Yes 118 23.21 ± 8.41
Does he/she take active cytotoxic KT?
 No 340 22.85 ± 8.59 0.617
 Yes 146 22.38 ± 8.63